HYBRIGENICS: Videoconference for Hybrigenics shareholders and all individual investors on November 30, 2022 at 6:30 p.m. – Presentation of the strategic plan – 11/16/2022 at 6:00 p.m.


Illkirch, November 16, 2022 – 6 p.m.

– On the occasion of the presentation of the new strategic plan which aims to guide the company’s strategy in the value chain of therapeutic treatments at the service of players in the pharmaceutical and biotechnology industry,

Hybrigenics SA (Euronext Paris – FR0004153930 – ALHYG)

is pleased to invite its shareholders and all individual investors to a videoconference:

Wednesday, November 30, 2022

at 6:30 p.m.

During this videoconference, Léone Atayi, Chief Executive Officer, will detail the three phases of the new strategic plan:

  • The sentence ”

    Renaissance

    “, on the affirmation of the new identity of the Group and the restoration of growth and cash generation.

  • The sentence ”

    Transformation

    “, aiming to evolve the business model of Hybrigenics in the value chain of the development of therapeutic treatments.

  • The sentence ”

    Expansion”

    accelerating the deployment and international growth of the Group.

Léone Atayi, Chief Executive Officer, will also answer questions from shareholders and individual investors on this strategic plan and Hybrigenics’ outlook.

To register, please click on the link below:

Registration link for the videoconference of November 30, 2022

You can also send your questions by email to

[email protected]

.


About Hybrigenics


Hybrigenics is a listed biopharmaceutical company (ALHYG) in Paris on the Euronext Growth market of Euronext, eligible for the PEA-PME.

Hybrigenics and its subsidiaries make up the DMS Biotech division, which supports the development strategy of DMS Group (Euronext Paris – FR0012202497 – DGM) in the field of biotechnology. It specializes in the development of biotherapy solutions in different therapeutic areas.

More information at www.hybrigenics.com.


Hybrigenics

is listed on the Euronext Growth market of Euronext Paris

ISIN: FR0004153930 – Memo: ALHYG – PEA-PME eligible

Hybrigenics


Leone ATAYI

Executive Director

[email protected]

09 71 04 32 63


This post has the “? Actusnews SECURITY MASTER” service.


– SECURITY MASTER Key:

yXBxZMpqammanm9rZZZlZmdsZmZhxGjKZ2iXk2VuY5mXnJ1nnGhjmMrHZnBol2pu

– To check this key:

https://www.security-master-key.com.



Regulated information:


Inside information:

– Other press releases


Full and original press release in PDF format:

https://www.actusnews.com/news/77258-hybrigenics_cp_webinar-investors-30112022-en.pdf

© Copyright Actusnews Wire

Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com



Source link -86